Fact check
“Because Upsher-Smith Laboratories, LLC., U.S. Agent for Sawai USA, Inc., timely requested that approval of the ANDA not be withdrawn, the approval is still in effect.”
Reasoning
The claim concerns a specific regulatory action regarding an ANDA approval and a request by Upsher‑Smith Laboratories. Without any provided documents, databases, or statements from the FDA or involved parties, there is no basis to assess the factual status of the claim.
On confidence: No evidence was supplied to confirm or refute the claim.
Important context
Verification would require access to FDA records, correspondence from Upsher‑Smith Laboratories, or official notices about the ANDA status.
Evidence
No retrievable evidence was found; the verdict rests on the reporting itself and is marked accordingly.
Limitations
The assessment is limited to the absence of supplied evidence; no external sources were consulted.
- Last verified:
- Oct 6, 2026, 4:13 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications; CorrectionFederal Register · Drug Administration, Human Services Department, Food, Health